Epithelial-mesenchymal transition (EMT) is now well documented to be involved in the development of endometriosis through the promotion of invasion and fibrogenesis. To date, several factors have been reported to be involved in EMT in endometriosis. The eukaryotic translation initiation factor 3 subunit e (eIF3e) protein is a component of the multisubunit eIF3 complex essential for cap-dependent translation initiation. The aim of this study was to investigate whether eIF3e is involved in EMT in endometriosis. We recruited 40 premenopausal women (34.7 [6.8] years) with laparoscopically and histologically diagnosed ovarian endometriomas, and their ectopic endometrial tissue samples were collected after informed consent. As controls, endometrial tissue samples were obtained after informed consent from 40 premenopausal women, roughly age-matched (36.9 [6.4] years) and menstrual phase-matched with endometriosis group, who underwent surgery for benign gynecologic disorders or cervical intraepithelial neoplasia but without endometriosis, adenomyosis, or uterine fibroids. All tissue samples were subjected to immunohistochemistry analysis of eIF3e, transforming growth factor (TGF-b1), Snail, E-cadherin, vimentin, and proliferating cell nuclear antigen (PCNA). We found significantly reduced immunoreactivity against eIF3e and E-cadherin but elevated immunoreactivity against TGF-b1, Snail, vimentin, and PCNA in endometriotic epithelial cells when compared to that of control endometrium (all P values <.05). The eIF3e staining levels correlated negatively with that of TGF-b1 and Snail but positively with that of E-cadherin (all P values <.05). These data suggest that eIF3e downregulation may be involved in EMT in endometriosis, possibly through preferential translation of Snail. Future studies are warranted to confirm whether this is the mechanism.
Introduction
Endometriosis, characterized by the presence and growth of functional endometrial-like tissues outside the uterine cavity, is an estrogen-dependent disorder affecting 6% to 10% of reproductive-age women. 1 It is a major contributor to pelvic pain and subfertility and impacts negatively on women's quality of life, work productivity, sexual relationship, and selfesteem, mainly because of chronic, incapacitating pain and infertility. [2] [3] [4] [5] [6] Despite its prevalence and extensive research, its pathogenesis and pathophysiology still remain poorly understood. 7 Endometriotic cells have long been recognized to have increased invasiveness, 8 and this invasiveness is well known to be tied to the downregulation of E-cadherin, 9, 10 that is, the loss of epithelial cell phenotype as a result of a cellular process known as the epithelial-mesenchymal transition (EMT). 11 The EMT is a complex cellular process that converts immotile epithelial cells to motile mesenchymal cells during embryonic development, cancer, and as a physiological response to injury. 11 It is regulated by several transcription factors, such as Snail and Zeb2, that repress the expression of genes required for the epithelial phenotype while simultaneously induce the expression of genes required for mesenchymal properties. 12 In endometriosis, the role of EMT in the development of endometriosis has received increasing attention mostly due to the invasiveness of endometriotic epithelial cells. 8, 9 So far, aberrant tumor necrosis factor a-induced signaling, 13 steroid receptor coactivator 1 variant, 14 the Wnt/b-catenin signaling pathway, 15 lipocalin 2, 16 estrogen-mediated hepatocyte growth factor, 17 lysyl oxidase, 18 estrogen receptor b, 19 platelet-derived transforming growth factor b1 (TGF-b1), 20 periostin, 21 hypoxia-inducible factor 1a, 22 and possibly lysine-specific demethylase 1 23 have been reported to be involved, perhaps in varying extent, in EMT in endometriosis. Aside from the delineation of the molecular mechanisms underlying EMT in endometriosis, it is also desirable to identify all key factors involved in EMT in endometriosis.
Translational control plays a major role in regulating protein expression and occurs primarily at the initiation step, which is controlled by multiple eukaryotic translation initiation factors (eIFs) 24 and is important for health and disease since the initiation is rate limiting for most messenger RNAs (mRNAs). 25 eIF3 is the largest family of protein translation initiation factors comprising 13 nonidentical subunits (3a-3m) that regulate translation initiation by orchestrating the formation of 43S-48S preinitiation complexes. 25 In particular, eIF3e, also known as Int6, is a core component of the eIF3 multisubunit translation initiation complex. 26 Downregulation of eIF3e has been reported to cause EMT in breast and lung cancers, 27, 28 owing to its preferential cap-independent translation of vimentin and EMT transcription factor Zeb2. 28 In addition, eIF3e silencing promotes wound healing through increased angiogenesis. 29 As endometriotic lesions are fundamentally wounds that undergo repeated tissue injury and repair, 20, 30, 31 we hypothesized that eIF3e may also play a role in EMT in endometriosis. Using immunohistochemistry (IHC) analysis, we evaluated the expression of eIF3e in ectopic endometrium when compared to control endometrium. In addition, we evaluated the immunoreactivity against markers of EMT and TGF-b1, a prototypical inducer of EMT. 11 Our data demonstrated that eIF3e is likely involved in EMT in endometriosis.
Methods and Materials

Patients and Tissue Samples
This study was approved by the ethics review board of Shanghai Obstetrics and Gynecology Hospital, Fudan University. Forty patients with endometriosis, seen at Shanghai Obstetrics and Gynecology Hospital from August 2015 to January 2016, diagnosed by transvaginal ultrasound before surgery and histologically confirmed postoperatively, were recruited as endometriosis group. After informed consent, their ectopic endometrial tissue samples were collected during laparoscopic cystectomy of ovarian endometrioma and immediately fixed in 10% buffered formalin and then processed for paraffin embedding. For controls, we also collected, after informed consent, endometrial tissue samples through curettage from 40 women seen at Shanghai Obstetrics and Gynecology Hospital, Fudan University, during the same period. Among the 40 controls, 7 (17.5%) had teratoma, 28 (70.0%) were diagnosed with cervical intraepithelial neoplasia III, 3 (7.5%) had stage Ia1 cervical cancer, and 2 (5.0%) had cervical carcinoma in situ. None of them had any clinical indication or history of endometriosis or adenomyosis. The selection of the controls was based solely on menstrual phase besides disease status and, to a lesser extent, age. The characteristics of patients with endometriosis and controls are listed in Table 1 .
Immunohistochemistry
Serial 4-mm sections were obtained from each paraffinembedded tissue block, with the first resultant slide being stained with hematoxylin and eosin to confirm pathologic diagnosis and the subsequent slides stained for IHC. Routine deparaffinization and rehydration procedures were performed.
We performed IHC analyses of eIF3e, TGF-b1, E-cadherin, vimentin, proliferating cell nuclear antigen (PCNA), and Snail. The catalog number antibody names, vendor names, and the concentrations used in this study are listed in Supplemental Table S1 .
For antigen retrieval, the slides were heated at 98 C in citrate buffer (pH 6.0) for a total of 30 minutes and cooled naturally at room temperature. Sections were then incubated overnight with the primary antibody at 4 C. After slides were rinsed, the biotinylated secondary antibody, Supervision TM Universal (Anti-Mouse/Rabbit) Detection Reagent (horse reddish peroxidase, GK500705; Shanghai Gene Tech Company, Shanghai), was incubated at room temperature for 30 minutes. The bound antibody complexes were stained for 3 to 5 minutes or until appropriate for microscopic examination with diaminobenzidine and then counterstained with hematoxylin and mounted.
As positive controls for IHC analysis, mouse spleen and liver samples were used for the positive immunostaining of vimentin and TGF-b1, respectively, and tissues of women's breast cancer were used for the positive immunostaining of eIF3e, E-cadherin, and Snail. For negative controls, phosphate-buffered saline was used instead of primary antibodies and the slides were exposed to secondary antibody alone. The negative controls did not show any nonspecific staining. The representative IHC results of positive and negative controls are shown in Figure S1 .
Immunoreactivity staining was characterized quantitatively by digital image analysis using the Image Pro-Plus 6.0 (Media Cybernetics, Inc, Bethesda, Maryland), as reported previously, 32 without prior knowledge of any of the clinicopathological information. Briefly, images were obtained with the microscope (Olympus BX51; Olympus, Tokyo, Japan) fitted with a digital camera (Olympus DP70; Olympus). A series of 10 random images on several sections were taken for each immunostained parameter to obtain a mean value. Staining was defined via color intensity, and a color mask was made. The mask was then applied equally to all images, and measurements were obtained. The IHC parameters assessed in the area detected included (1) integrated optical density (IOD), (2) total stained area (S), and (3) mean optical density (MOD), which is defined as MOD ¼ IOD/S, equivalent to the intensity of stain in the positive cells.
For all IHC markers, their immunoreactivity was scored exclusively in the epithelial component of ectopic or control endometrium. This is because, first, the positive staining of vimentin, TGF-b1, eIF3e, E-cadherin, Snail, and PCNA was seen more prominently in epithelial cells than stromal cells in ectopic lesions, and second, our focus was on EMT. To minimize potential bias, we first calibrated the intensity for all slides (including those from control endometrial tissue samples) by setting a universal threshold of intensity in the Image Pro Plus, leaving out the nonspecific or much weaker staining in the stromal component. In addition, we focused on the epithelial or stromal component through the adroit use of the masking tool of the imaging software, excluding as much as possible the signals from the other components. Sections of control endometrium were evaluated and analyzed in the same manner.
Statistical Analysis
For descriptive statistics, we used box plot 33 to graphically depict groups of immunoreactivity data. The comparison of distributions of continuous variables between or among 2 or more groups was made using the Wilcoxon test and KruskalWallis test, respectively. Pearson or Spearman rank correlation coefficient was used when evaluating correlations between the 2 variables when both variables are continuous or when at least 1 variable is ordinal. The relationship between various clinical and pathological parameters was compared with w 2 tests. To evaluate whether the source of tissue samples is associated with the differences in immunoreactivity while controlling for other factors, such as menstrual phase and age, multiple linear regression analysis was used after square-root transformed to improve normality (if deemed to be necessary).
P values <.05 were considered statistically significant. All computations were made with R 3.3.1 34 (www.r-project.org).
Results
Clinicopathological Data
The characteristics of the patients and the controls are shown in Table 1 . The endometriosis group was comparable with the control group in age but had significantly lower parity and lower proportion in proliferative phase and had more severe dysmenorrhea (Table 1) .
Evidence for Reduced eIF3e Expression, Activation of TGF-b/Smad Pathway, Occurrence of EMT, and Increased Proliferation in Ectopic Endometrium
We first investigated the eIF3e immunoreactivity in ectopic and control endometrium. The micrographs of eIF3e immunoreactivity in eutopic and control endometrium are shown in Figure 1 . We found that the eIF3e immunostaining is located primarily in the epithelial component in both ectopic and control endometrium and does not vary significantly between proliferative and secretory phases in either control or ectopic endometrium (P ¼ .26 and P ¼ .88, respectively). However, the eIF3e immunostaining levels in epithelium in ectopic endometrium were significantly lower than that in the control endometrium (P ¼ 5.0 Â 10 À13 ; Figures 1 and 2A ). Using age, menstrual phase, parity, and source of tissue samples (control vs ectopic endometrium) as covariables, the multiple linear regression analysis identified that the source of tissue samples was the only covariable that was significantly associated with the eIF3e staining levels (P < 2.2 Â 10 À16 , R 2 ¼ .67). The lesional eIF3e staining levels had no relationship with age, the menstrual phase, parity, severity of dysmenorrhea, revised American Society of Reproductive Medicine classification (rASRM) score, the size of the largest endometriomas, or cooccurrence of uterine myoma (all P values >.42).
To further understand the possible role of eIF3e in EMT and cellular proliferation, we performed immunostaining of ectopic and control endometrium using antibodies against TGF-b1, Snail, E-cadherin, vimentin, and PCNA, the proliferation marker. PCNA was expressed positive mostly in the nuclei of epithelial cells and a few stromal cells in ectopic tissue and was significantly elevated when compared to the controls (Figure 1) . Snail showed a positive staining in the nuclei of epithelial and stromal cells in ectopic endometrium but not in control endometrium. Transforming growth factor b1 showed a positive staining in the cytoplasm of ectopic epithelium, in contrast to negative staining in the control group. E-cadherin was expressed in the membrane of epithelial cells of both ectopic and control endometrium, but its staining was significantly reduced in ectopic endometrium. The immunoreactivity against vimentin was seen in the cytoplasm of exclusively stromal cells in control endometrium, but in ectopic endometrium, the cytoplasm of some epithelial cells was also stained positive ( Figure 1 ).
As expected, we found that in the epithelial component of ectopic endometrium, the immunostaining levels of TGF-b1, Snail, vimentin, and PCNA were significantly higher than that in the control endometrium, while the E-cadherin staining levels were the opposite (all P values <.05; Figures 1 and 2) . After controlling for age, menstrual phase, and parity, the results still remained the same (all P values <.003 by multiple linear regression analyses).
We found that the eIF3e staining levels correlated negatively with that of TGF-b1 and Snail but positively with that of E-cadherin ( Figure 3A-C) . As expected, the Snail staining levels correlated negatively with that of E-cadherin ( Figure 3D ).
Discussion
In this study, we found that eIF3e immunoreactivity is significantly reduced in ectopic endometrium when compared to control endometrium, concomitant with increased immunoreactivity against TGF-b1, Snail, and vimentin but reduced staining of E-cadherin in endometriotic epithelial cells. In addition, we found that the eIF3e staining levels correlated positively with that of E-cadherin but negatively with that of TGF-b1, Snail, and vimentin. The immunostaining levels of PCNA in epithelium of ectopic endometrium were significantly higher than that of the control endometrium. These data are consistent with the notion that eIF3e may be involved in EMT in endometriosis through the activation of TGF-b1 28 and may also facilitate cellular proliferation through increased angiogenesis in ectopic endometrium. 29 Our data are consistent with the reported observation that EMT occurs in endometriosis 13, 20, 31, 35 and with the increased TGF-b1 and Snail expression in endometriosis. [36] [37] [38] Transforming growth factor b1 is a prototypical factor in EMT, 11 and the EMT program can be induced by extrinsic signals such as TGF-b1. 39 In endometriosis, platelet-derived TGF-b1 activates the TGF-b1/Smad3 signaling pathway, resulting in EMT, fibroblast-to-myofibroblast (FMT), smooth muscle metaplasia, and fibrogenesis. 20 Snail is a repressor of E-cadherin, and its overexpression results in suppression of E-cadherin, leading to EMT. 11 The positive correlation between eIF3e and E-cadherin staining and the negative correlation between eIF3e and Snail staining and between eIF3e and TGF-b1 staining as shown in this study suggest that eIF3e downregulation may be involved in EMT in endometriosis.
Due to the cross-sectional nature of our study, while the best we can say is that eIF3e may be involved in EMT in endometriosis, there are other indications that eIF3e may play a role in EMT and perhaps other aspects of pathophysiology in endometriosis. First, the mRNAs of Snail and Zeb2, the 2 major regulators of EMT, 11 have been reported to be preferentially translated, 27 and the cap-independent translation of Zeb2 and vimentin is favored 28 when eIF3e expression is reduced, which may also be true for endometriotic epithelial cells. Incidentally, Y-box-binding protein 1, a protein that regulates translation initiation, has been reported to be overexpressed in endometriosis. 40 Since eIF3e is a component of the multisubunit translation initiation complex eIF3, 26 it is likely that eIF3e downregulation in endometriosis may result in increased translation of Snail and Zeb2. Second, eIF3e silencing has been shown to promote functional blood vessel outgrowth and enhances wound healing, 29 yet increased angiogenesis is one prominent feature of endometriotic lesions. 41 Third, eIF3e downregulation activates stromal fibroblasts, leading to increased stromal cell-derived factor 1 (SDF-1) secretion, 42 yet SDF-1 secretion and the expression of its receptor, CXCR4, have been reported to be elevated in endometriosis. 43, 44 These evidences are of course circumstantial and further investigation is warranted. Figure 2 . Summary of the differential immunoreactivity between control and ectopic endometrium. Box plots showing differential immunoreactivity against eukaryotic translation initiation factor 3 subunit e (eIF3e; A), transforming growth factor b1 (TGF-b1; B), Snail (C), E-cadherin (D), vimentin (E), and proliferating cell nuclear antigen (PCNA; F) in control and ectopic endometrium. **P < .01; ***P < .001.
While so far several cytokines and transcription factors have been shown to be involved in EMT in endometriosis, not a single factor involved in translation control has been reported to be involved. In fact, no such factor has ever been reported for endometriosis. A recent global transcriptome analysis of eutopic endometrium in women with adenomyosis found the involvement of eIF2 signaling pathway. 45 In principle, aberrant translation control may also be involved in the development of endometriosis. It should be noted that while so far all factors reported to be involved in EMT in endometriosis are aberrantly overexpressed, here eIF3e expression is found to be reduced. In theory, forced expression of eIF3e in endometriotic epithelial cells should immediately tell us whether our suspicion is true or not.
In conclusion, we provide evidence that eIF3e immunoreactivity is reduced in ectopic endometrium, concomitant with increased expression of TGF-b1, Snail, and vimentin but reduced expression of E-cadherin in endometriotic epithelial cells. These data suggest that eIF3e downregulation may be involved in EMT in endometriosis. Since translation control has not been investigated systemically in endometriosis, this study hopefully can pique interest in this rapidly developing area.
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